Akums Drugs IPO now open for subscription: Check Anil Singhvi's view before subscribing
Akums Drugs IPO Review By Anil Singhvi: The initial public offering (IPO) of Akums Drugs and Pharmaceuticals Ltd is now open for public subscription. Ahead of that, Akums Drugs said it has collected Rs 829 crore from anchor investors. The Rs 1,875-crore IPO is a combination of a fresh issue of equity shares worth Rs 680 crore and an offer for sale (OFS) of 1.73 crore shares valued at Rs 1,177 crore at the upper end of the price band by promoters and an existing investor. (File Photos)
Akums Drugs IPO: Company's Mcap
Akums Drugs IPO Review By Anil Singhvi: Brokerage houses have pegged the company's market capitalisation at Rs 10,697 crore post-issue. Here's the Akums Drugs IPO review by market wizard Anil Singhvi that you must read before subscribing to the IPO.
Akums Drugs IPO Review By Anil Singhvi
According to Zee Business Managing Editor Anil Singhvi, one should subscribe to Akums Drugs IPO for reasonable listing gains. Here are some positives and negatives listed by him.
Akums Drugs IPO Positives By Anil Singhvi
- Experienced promoters
- Leading CDMO Pharma player
- Strong R&D focus to ensure future growth
- Full Domestic business so no risk to USFDA approvals
- Attractive valuations
Akums Drugs IPO Negatives By Anil Singhvi
- High inventory levels
-Low margin business
-Entry into highly competitive API business
Akums Drugs IPO Subscription Dates
Akums Drugs IPO Review: The Akums Drugs and Pharma IPO will remain open for subscription till August 1.
Akums Drugs IPO Price Band
Akums Drugs IPO Review: Akums Drugs and Pharmaceuticals IPO has a price band of Rs 646 to Rs 679 per equity share with a face value of Rs 2.
Akums Drugs IPO Lot Size
Akums Drugs IPO Review: The issue has a lot size of 22 equity shares and in multiples of 22 equity shares thereafter.
Akums Drugs IPO Allotment Date
Akums Drugs IPO Review: The Akums Drug IPO basis for share allotment is reportedly scheduled for August 2.
Akums Drugs IPO Listing Date
Akums Drugs IPO Review: Akums Drugs shares are expected to be listed on BSE and NSE on Tuesday, August 6.
Akums Drugs IPO: What does the company do?
Akums Drugs IPO Review: Founded in 2004, Akums is a pharmaceutical contract development and manufacturing organization (CDMO), offering a comprehensive range of pharmaceutical products and services in India and overseas.
Akums Drugs IPO: Lead Managers
Akums Drugs IPO Review: ICICI Securities, Axis Capital, Citigroup Global Markets India and Ambit Pvt Ltd are the running lead managers to the issue.
Akums Drugs IPO: Registrar For Issue
Akums Drugs IPO Review: Link Intime India Private Ltd is the registrar for the issue.